139 related articles for article (PubMed ID: 1673495)
1. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
Hui KP; Barnes NC
Lancet; 1991 May; 337(8749):1062-3. PubMed ID: 1673495
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
3. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
[TBL] [Abstract][Full Text] [Related]
5. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
6. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
Findlay SR; Barden JM; Easley CB; Glass M
J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
[TBL] [Abstract][Full Text] [Related]
7. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
Smith LJ; Glass M; Minkwitz MC
Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
[TBL] [Abstract][Full Text] [Related]
9. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
10. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
[TBL] [Abstract][Full Text] [Related]
11. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
Makker HK; Lau LC; Thomson HW; Binks SM; Holgate ST
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
[TBL] [Abstract][Full Text] [Related]
13. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
[TBL] [Abstract][Full Text] [Related]
15. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
Dahlén B; Zetterström O; Björck T; Dahlén SE
Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
[TBL] [Abstract][Full Text] [Related]
16. Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma.
Carratù P; Morelli N; Freire AX; Pugazhenthi M; Guerra S; Umberger R; Allegra L
Respiration; 2003; 70(3):249-53. PubMed ID: 12915743
[TBL] [Abstract][Full Text] [Related]
17. Effect of zafirlukast on cough reflex sensitivity in asthmatics.
Dicpinigaitis PV; Dobkin JB
J Asthma; 1999 May; 36(3):265-70. PubMed ID: 10350223
[TBL] [Abstract][Full Text] [Related]
18. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma.
Nathan RA; Glass M; Minkwitz MC
Chest; 1994 Feb; 105(2):483-8. PubMed ID: 8306751
[TBL] [Abstract][Full Text] [Related]
19. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
Barnes NC; Pujet JC
Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
[TBL] [Abstract][Full Text] [Related]
20. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
